| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 10.92B | 10.21B | 10.52B | 11.15B | 13.69B |
| Gross Profit | 2.33B | 2.00B | 1.84B | 1.87B | 2.46B |
| EBITDA | 1.44B | 1.17B | 952.65M | 827.81M | 1.18B |
| Net Income | 1.27B | 1.02B | 645.44M | 400.45M | 1.28B |
Balance Sheet | |||||
| Total Assets | 16.92B | 15.47B | 15.62B | 15.39B | 16.60B |
| Cash, Cash Equivalents and Short-Term Investments | 6.82B | 5.98B | 5.75B | 3.71B | 4.08B |
| Total Debt | 2.15B | 5.81M | 732.37M | 714.47M | 655.98M |
| Total Liabilities | 5.44B | 4.77B | 5.64B | 5.64B | 6.40B |
| Stockholders Equity | 11.48B | 10.70B | 9.98B | 9.75B | 10.20B |
Cash Flow | |||||
| Free Cash Flow | 1.21B | 1.28B | 1.80B | 1.62B | 37.28M |
| Operating Cash Flow | 1.27B | 1.37B | 1.98B | 1.86B | 419.68M |
| Investing Cash Flow | 2.33B | -3.01B | -58.70M | -999.69M | -105.64M |
| Financing Cash Flow | -474.33M | -615.43M | -458.29M | -854.23M | -1.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$13.87B | 8.98 | 11.57% | 4.26% | 9.84% | 27.75% | |
66 Neutral | HK$102.93B | 4.80 | 14.20% | 4.77% | 15.34% | 20.27% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | HK$36.32B | 13.19 | 13.75% | 3.41% | 11.08% | 59.37% | |
57 Neutral | HK$73.50B | 19.02 | 7.49% | 7.28% | 14.66% | 30.39% | |
51 Neutral | HK$2.33B | -80.02 | -1.07% | ― | 5.97% | 53.11% | |
39 Underperform | HK$1.06B | -5.14 | -10.95% | ― | -10.77% | -25.12% |